Download pdf
EVs as biomarkers of cardiovascular disease
- 1 Tibet University
* Author to whom correspondence should be addressed.
Abstract
Exosomes are an emerging research direction in biology, and their current definition is: “Exosomes are small vesicles (30-150nm) containing complex RNA and proteins, and nowadays, they are specifically dish-like vesicles with diameters of 40-100nm.” Many cells can produce exosome under physiological or physiological conditions. The mechanism is formed by the deposition of polyvesicles after binding to the extracellular membrane. Therefore, it can be seen from this definition that exosomes are a general term for a large class of vesicle-wrapped biological contents, which are physiological substances used by organisms to maintain normal physiological activities. Therefore, exosomes have a very rich classification, subclasses, and subsets.
Keywords
Exosomes, disease, cell.
[1]. Chen, Z., Larregina, A. T., & Morelli, A. E. (2019). Impact of extracellular vesicles on innate immunity. Curr Opin Organ Transplant, 24(6), 670-678. doi:10.1097/MOT.0000000000000701
[2]. Chong, S. Y., Lee, C. K., Huang, C., Ou, Y. H., Charles, C. J., Richards, A. M., Wang, J. W. (2019). Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers. Int J Mol Sci, 20(13). doi:10.3390/ijms20133272
[3]. de Freitas, R. C. C., Hirata, R. D. C., Hirata, M. H., & Aikawa, E. (2021). Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases. Biomolecules, 11(3). doi:10.3390/biom11030388
[4]. Femmino, S., Penna, C., Margarita, S., Comita, S., Brizzi, M. F., & Pagliaro, P. (2020). Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors. Vascul Pharmacol, 135, 106790. doi:10.1016/j.vph.2020.106790
[5]. Hutcheson, J. D., & Aikawa, E. (2018). Extracellular vesicles in cardiovascular homeostasis and disease. Curr Opin Cardiol, 33(3), 290-297. doi:10.1097/HCO.0000000000000510
[6]. Jansen, F., Nickenig, G., & Werner, N. (2017). Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology. Circ Res, 120(10), 1649-1657. doi:10.1161/CIRCRESAHA.117.310752
[7]. Kim, O. Y., Lee, J., & Gho, Y. S. (2017). Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines. Semin Cell Dev Biol, 67, 74-82. doi:10.1016/j.semcdb.2016.12.001
[8]. Marin, D., & Scott, R. T., Jr. (2018). Extracellular vesicles: a promising tool for assessment of embryonic competence. Curr Opin Obstet Gynecol, 30(3), 171-178. doi:10.1097/GCO.0000000000000458
[9]. Miyaki, S., & Lotz, M. K. (2018). Extracellular vesicles in cartilage homeostasis and osteoarthritis. Curr Opin Rheumatol, 30(1), 129-135. doi:10.1097/BOR.0000000000000454
[10]. Osteikoetxea, X., Nemeth, A., Sodar, B. W., Vukman, K. V., & Buzas, E. I. (2016). Extracellular vesicles in cardiovascular disease: are they Jedi or Sith? J Physiol, 594(11), 2881-2894. doi:10.1113/JP271336
[11]. Pfeifer, P., Werner, N., & Jansen, F. (2015). Role and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular Biology. Biomed Res Int, 2015, 161393. doi:10.1155/2015/161393
[12]. Urabe, F., Kosaka, N., Kimura, T., Egawa, S., & Ochiya, T. (2018). Extracellular vesicles: Toward a clinical application in urological cancer treatment. Int J Urol, 25(6), 533-543. doi:10.1111/iju.13594
[13]. Yang, X., Song, X., Li, Z., Liu, N., Yan, Y., & Liu, B. (2021). Crosstalk between extracellular vesicles and autophagy in cardiovascular pathophysiology. Pharmacol Res, 172, 105628. doi:10.1016/j.phrs.2021.105628
Cite this article
Cao,S. (2024). EVs as biomarkers of cardiovascular disease. Theoretical and Natural Science,46,61-64.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Modern Medicine and Global Health
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).